|
NOL7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.435230E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.189680E-02 |
| Normal-vs-Stage2 |
3.418800E-03 |
| Normal-vs-Stage3 |
3.23390000334101E-08 |
| Normal-vs-Stage4 |
2.378000E-03 |
| Stage1-vs-Stage2 |
1.740210E-01 |
| Stage1-vs-Stage3 |
7.60790000000622E-05 |
| Stage1-vs-Stage4 |
1.969780E-01 |
| Stage2-vs-Stage3 |
3.066000E-01 |
| Stage2-vs-Stage4 |
7.028600E-01 |
| Stage3-vs-Stage4 |
5.527900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.018510E-04 |
| Normal-vs-AfricanAmerican |
9.999700E-02 |
| Normal-vs-Asian |
1.185040E-04 |
| Caucasian-vs-AfricanAmerican |
1.761790E-01 |
| Caucasian-vs-Asian |
3.374200E-02 |
| AfricanAmerican-vs-Asian |
9.303800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64449999999761E-05 |
| Normal-vs-Female |
2.623900E-02 |
| Male-vs-Female |
9.390600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.601800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.597190E-03 |
| Normal-vs-Age(61-80Yrs) |
2.043000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.636550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.027800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.698800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.543400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.410200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.636800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.299600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.575800E-01 |
| Normal-vs-Grade 2 |
3.858300E-02 |
| Normal-vs-Grade 3 |
7.03350000019753E-07 |
| Normal-vs-Grade 4 |
3.72189999997552E-06 |
| Grade 1-vs-Grade 2 |
1.091430E-01 |
| Grade 1-vs-Grade 3 |
2.076100E-03 |
| Grade 1-vs-Grade 4 |
3.082400E-03 |
| Grade 2-vs-Grade 3 |
1.772650E-04 |
| Grade 2-vs-Grade 4 |
1.982290E-04 |
| Grade 3-vs-Grade 4 |
2.549200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.898600E-01 |
| Normal-vs-ccB subtype |
4.90440021927441E-10 |
| ccA subtype-vs-ccB subtype |
6.21724893790088E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.45869999999848E-05 |
| Normal-vs-N1 |
2.193400E-04 |
| N0-vs-N1 |
6.028200E-02 |
|
|
